Skip to main content
SpringerLink
Log in

Moraxella catarrhalis

  • Chapter
New Bacterial Vaccines

Part of the book series: Medical Intelligence Unit ((MIUN))

  • 164 Accesses

Abstract

The recognition of Moraxella catarrhalis in the past two decades as an important human respiratory tract pathogen has stimulated much interest in research on the organism. Recent work has unequivocally established M. catarrhalis as a common cause of otitis media and of lower respiratory tract infection in adults with chronic lung disease. Knowledge of the epidemiology of respiratory tract colonization by M. catarrhalis and an understanding of its antigenic structure is expanding rapidly. These observations along with the growing understanding of the human immune response to M. catarrhalis will form the basis of rational vaccine development. This chapter will review progress in the area and propose approaches which will lead to successful vaccine development to prevent infections caused by M. catarrhalis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aebi C, Cope LD, Latimer JL et al. Mapping a protective epitope of the CopB outer membrane protein of Moraxella catarrhalis. Infect Immun 1998; 66:540–8.

    PubMed  CAS  Google Scholar 

  2. Aebi C, LaFontaine ER, Cope LD et al. Phenotypic effect of isogenic uspAl and uspA2 mutations on Moraxella catarrhalis 035E. Infect Immun 1998; 66:3113–9.

    PubMed  CAS  Google Scholar 

  3. Aebi C, Maciver I, Latimer JL et al. A protective epitope of Moraxella catarrhalis is encoded by two different genes. Infect Immun 1997; 65:4367–77.

    PubMed  CAS  Google Scholar 

  4. Aebi C, Stone B, Beucher M et al. Expression of the CopB outer membrane protein by Moraxella catarrhalis is regulated by iron and affects iron acquisition from transferrin and lactoferrin. Infect Immun 1996; 64:2024–30.

    PubMed  CAS  Google Scholar 

  5. Aniansson G, Alm B, Andersson B et al. Nasopharyngeal colonization during the first year of life. J Infect Dis 1992; 165(S1):S38–S42.

    Article  PubMed  Google Scholar 

  6. Aspin MM, Hoberman A, McCarty J et al. Comparative study of the safety and efficacy of clarithromycin and amoxicillin-clavulanate in the treatment of acute otitis media in children. J Pediatr 1994; 125:135–41.

    Google Scholar 

  7. Bakaletz LO, Murwin DM, Billy JM. Adenovirus serotype 1 does not act synergistically with Moraxella (Branhamella) catarrhalis to induce otitis media in the chinchilla. Infect Immun 1995; 63:4188–90.

    PubMed  CAS  Google Scholar 

  8. Bakri F, Brauer AL, Sethi S et al. Systemic and mucosal antibody response to Moraxella catarrhalis following exacerbations of chronic obstructive pulmonary disease. J Infect Dis 2001; in press.

    Google Scholar 

  9. Barreiro B, Esteban L, Prats E et al. Branhamella catarrhalis respiratory infections. Eur Respir J 1992; 5:675–9.

    PubMed  CAS  Google Scholar 

  10. Beaulieu D, Scriver S, Bergeron MG et al. Epidemiological typing of Moraxella catarrhalis by using DNA probes. J Clin Microbiol 1993; 31:736–9.

    PubMed  CAS  Google Scholar 

  11. Bhushan R, Craigie R, Murphy. Molecular cloning and characterization of outer membrane protein E of Moraxella (Branhamella) catarrhalis. J Bacteriol 1994; 176:6636–43.

    PubMed  CAS  Google Scholar 

  12. Bhushan R, Kirkham C, Sethi S et al. Antigenic characterization and analysis of the human immune response to outer membrane protein E of Branhamella catarrhalis. Infect Immun 1997; 65:2668–75.

    PubMed  CAS  Google Scholar 

  13. Block SL, Hedrick JA, Kratzer J et al. Five-day twice daily cefdinir therapy for acute otitis media: microbiologic and clinical efficacy. Pediatr Infect Dis J 2000; 19(12S):S153–S158.

    PubMed  CAS  Google Scholar 

  14. Block SL, McCarty JM, Hedrick JA et al. Comparative safety and efficacy of cefdinir vs amoxicillin/clavulanate for treatment of suppurative acute otitis media in children. Pediatr Infect Dis J 2000; 19:S159–S165.

    Article  PubMed  CAS  Google Scholar 

  15. Bonnah RA, Wong H, Loosmore SM et al. Characterization of Moraxella (Branhamella) catarrhalis lbpB, lpbA, and lactoferrin receptor orf3 isogenic mutants. Infect Immun 1999; 67:1517–20.

    PubMed  CAS  Google Scholar 

  16. Bonnah RA, Yu R-H, Wong H et al. Biochemical and immunological properties of lactoferrin binding proteins from Moraxella (Branhamella) catarrhalis. Microb Pathogen 1998; 24:89–100.

    Article  CAS  Google Scholar 

  17. Brorson J-E, Axelsson A, Holm SE. Studies on Branhamella catarrhalis (Neisseria catarrhalis) with special reference to maxillary sinusitis. Scand J Infect Dis 1976; 8:151–5.

    PubMed  CAS  Google Scholar 

  18. Campagnari AA, Ducey TF, Rebmann CA. Outer membrane protein B1, an iron-repressible protein conserved in the outer membrane of Moraxella (Branhamella) catarrhalis, binds human transferrin. Infect Immun 1996; 64:3920–4.

    PubMed  CAS  Google Scholar 

  19. Carr B, Walsh JB, Coakley D et al. Prospective hospital study of community acquired lower respiratory tract infection in the elderly. Respir Med 1991; 85:185–7.

    Article  PubMed  CAS  Google Scholar 

  20. Chapman AJ, Musher DM, Jonsson S et al. Development of bactericidal antibody during Branhamella catarrhalis infection. J Infect Dis 1985; 151:878–82.

    Article  PubMed  Google Scholar 

  21. Chen D, Barniak V, Van der Meid KR et al. The levels and bactericidal capacity of antibodies directed against the uspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children. Infect Immun 1999; 67:1310–6.

    PubMed  CAS  Google Scholar 

  22. Chen D, McMichael JC, van der Meid KR et al. Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization. Infect Immun 1996; 64:1900–5.

    PubMed  CAS  Google Scholar 

  23. Chonmaitree T, Owen MJ, Patel JA et al. Effect of viral respiratory tract infection on outcome of acute otitis media. J Pediatr 1992; 120:856–62.

    Article  PubMed  CAS  Google Scholar 

  24. Choo PW, Gantz NM. Branhamella catarrhalis pneumonia with bacteremia. South Med J 1989; 82:1317–8.

    Article  PubMed  CAS  Google Scholar 

  25. Christensen JJ. Moraxella (Branhamella) catarrhalis: clinical, microbiological and immunological features in lower respiratory tract infections. APMIS 1999; 107(suppl):l–36.

    Google Scholar 

  26. Chung M-H, Enrique R, Lim DJ et al. Moraxella (Branhamella) catarrhalis-induced experimental otitis media in the chinchilla. Acta Otolaryngol. 1994; 114:415–22.

    Article  PubMed  CAS  Google Scholar 

  27. Collazos J, de Miguel J, Ayarza R. Moraxella catarrhalis bacteremic pneumonia in adults: two cases and review of the literature. Eur J Clin Microbiol Infect Dis 1992; 11:237–40.

    Article  PubMed  CAS  Google Scholar 

  28. Cook PP, Hecht DW, Snydman DR. Nosocomial Branhamella catarrhalis in a paediatric intensive care unit: risk factors for disease. J Hosp Infect 1989; 13:299–307.

    Article  PubMed  CAS  Google Scholar 

  29. Cope LD, LaFontaine ER, Slaughter CA et al. Characterization of the Moraxella catarrhalis uspA1 and uspA2 genes and their encoded products. J Bacteriol 1999; 181:4026–34.

    PubMed  CAS  Google Scholar 

  30. Dagan R, Leibovitz E, Greenberg D et al. Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome. Pediatr Infect Dis J 1998; 17:776–82.

    Article  PubMed  CAS  Google Scholar 

  31. DelBeccaro MA, Mendelman PM, Inglis AF et al. Bacteriology of acute otitis media: A new perspective. J Pediatr 1992; 120:81–4.

    Article  CAS  Google Scholar 

  32. Doyle WJ. Animal models of otitis media: other pathogens. Pediatr Infect Dis J 1989; 8:S45–S47.

    Article  PubMed  CAS  Google Scholar 

  33. Du R-P, Wang Q, Yang Y-P et al. Cloning and expression of the Moraxella catarrhalis lactoferrin receptor genes. Infect Immun 1998; 66:3656–65.

    PubMed  CAS  Google Scholar 

  34. Enright MC, McKenzie H. Moraxella (Branhamella) catarrhalis — clinical and molecular aspects of a rediscovered pathogen. J Med Microbiol 1997; 46:360–71.

    Article  PubMed  CAS  Google Scholar 

  35. Faden H. The microbiologic and immunologic basis for recurrent otitis media in children. Eur J Pediatr 2001; 160(7):407–13.

    Article  PubMed  CAS  Google Scholar 

  36. Faden H, Bernstein J, Stanievich J et al. Effect of prior antibiotic treatment on middle ear disease in children. Ann Otol Rhinol Laryngol 1992; 101:87–91.

    PubMed  CAS  Google Scholar 

  37. Faden H, Brodsky L, Waz MJ et al. Nasopharyngeal flora in the first three years of life in normal and otitis-prone children. Ann Otol Rhinol Laryngol 1991; 100:612–5.

    PubMed  CAS  Google Scholar 

  38. Faden H, Duffy L, Wasielewski R et al. Relationship between nasopharyngeal colonization and the development of otitis media in children. J Infect Dis 1997; 175:1440–5.

    Article  PubMed  CAS  Google Scholar 

  39. Faden H, Harabuchi Y, Hong JJ, Tonawanda/Williamsville Pediatrics. Epidemiology of Moraxella catarrhalis in children during the first 2 years of life: relationship to otitis media. J Infect Dis 1994; 169:1312–7.

    Article  PubMed  CAS  Google Scholar 

  40. Faden H, Hong J, Murphy TF. Immune response to outer membrane antigens of Moraxella catarrhalis in children with otitis media. Infect Immun 1992; 60:3824–9.

    PubMed  CAS  Google Scholar 

  41. Fagon J-Y, Chastre J, Trouillet J-L et al. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Am Rev Respir Dis 1990; 142:1004–8.

    PubMed  CAS  Google Scholar 

  42. Fitzgerald M, Mulcahy R, Murphy S et al. A 200 kDa protein is associated with haemagglutinating isolates of Moraxella (Branhamella) catarrhalis. FEMS Immunol Med Microbiol 1997; 18:209–16.

    Article  PubMed  CAS  Google Scholar 

  43. Fitzgerald M, Mulcahy R, Murphy S et al. Transmission electron microscopy studies of Moraxella (Branhamella) catarrhalis. FEMS Immunol Med Microbiol 1999; 23:57–66.

    PubMed  CAS  Google Scholar 

  44. Forsgren A, Brant M, Mollenkvist A et al. Isolation and characterization of a novel IgD-binding protein from Moraxella catarrhalis. J Immunol 2001; 167(4):2112–20.

    PubMed  CAS  Google Scholar 

  45. Fulghum RS, Marrow HG. Experimental otitis media with Moraxella (Branhamella) catarrhalis. Ann Otol Rhinol Laryngol 1996; 105:234–41.

    PubMed  CAS  Google Scholar 

  46. Gan VN, Kusmiesz H, Shelton S et al. Comparative evaluation of loracarbef and amoxicillin-ciavulanate for acute otitis media. Antimicrob Agents Chemother 1991; 35:967–71.

    Article  PubMed  CAS  Google Scholar 

  47. Gehanno P, Lenoir G, Barry B et al. Evaluation of nasopharyngeal cultures for bacteriologie assessment of acute otitis media in children. Pediatr Infect Dis J 1996; 15:329–32.

    Article  PubMed  CAS  Google Scholar 

  48. Gu X-X, Chen J, Barenkamp SJ et al. Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis. Infect Immun 1998; 66:1891–7.

    PubMed  CAS  Google Scholar 

  49. Harabuchi Y, Faden H, Yamanaka N et al. Nasopharyngeal colonization with nontypeable Haemophilus influenzae and recurrent otitis media. J Infect Dis 1994; 170:862–6.

    Article  PubMed  CAS  Google Scholar 

  50. Harabuchi Y, Murakata H, Goh M et al. Serum antibodies specific to CD outer membrane protein of Moraxella catarrhalis, P6 outer membrane protein of nontypeable Haemophilus influenzae and capsular polysaccharides of Streptococcus pneumoniae in children with otitis media with effusion. Acta Otolaryngol.(Stockh) 1998; 118:826–32.

    Article  CAS  Google Scholar 

  51. Harkness RE, Guimond MJ, McBey B-A et al. Branhamella catarrhalis pathogenesis in SCID and SCID/beige mice. APMIS 1993; 101:805–10.

    Article  PubMed  CAS  Google Scholar 

  52. Helminen ME, Maciver I, Latimer JL et al. A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model. Infect Immun 1993; 61:2003–10.

    PubMed  CAS  Google Scholar 

  53. Helminen ME, Maciver I, Latimer JL et al. A large, antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies. J Infect Dis 1994; 170:867–72.

    Article  PubMed  CAS  Google Scholar 

  54. Helminen ME, Maciver I, Paris M et al. A mutation affecting expression of a major outer membrane protein of Moraxella catarrhalis alters serum resistance and survival in vivo. J Infect Dis 1993; 168:1194–201.

    Article  PubMed  CAS  Google Scholar 

  55. Hendolin PH, Markkanen A, Ylikoski J et al. Use of multiplex PCR for simultaneous detection of four bacterial species in middle ear effusions. J Clin Microbiol 1997; 35:2854–8.

    PubMed  CAS  Google Scholar 

  56. Hendolin PH, Paulin L, Ylikoski J. Clinically applicable multiplex PCR for four middle ear pathogens. J Clin Microbiol 2000; 38:125–32.

    PubMed  CAS  Google Scholar 

  57. Hoiczyk E, Roggenkamp A, Reichenbecher M et al. Structure and sequence analysis of Yersinia YadA and Moraxella UspAs reveal a novel class of adhesins. EMBO 2000; 22:5989–99.

    Google Scholar 

  58. Holme T, Rahman M, Jansson P-E et al. The lipopolysaccharide of Moraxella catarrhalis. Structural relationships and antigenic properties. Eur J Biochem 1999; 265:524–9.

    Article  PubMed  CAS  Google Scholar 

  59. Hsiao CB, Sethi S, Murphy TF. Outer membrane protein CD of Branhamella catarrhalis: sequence conservation in strains recovered from the human respiratory tract. Microb Pathogen 1995; 19:215–25.

    Article  CAS  Google Scholar 

  60. Hu WG, Chen J, Battey JF et al. Enhancement of clearance of bacteria from murine lungs by immunization with detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins. Infect Immun 2000; 68(9):4980–5.

    Article  PubMed  CAS  Google Scholar 

  61. Hu W-G, Chen J, Collins FM et al. An aerosol challenge mouse model for Moraxella catarrhalis. Vaccine 2000; 18:799–804.

    Article  Google Scholar 

  62. Hu W-G, Chen J, McMichael JC et al. Functional characteristics of a protective monoclonal antibody against serotype A and C lipooligosaccharides from Moraxella catarrhalis. Infect Immun 2001; 69(3):1358–63.

    Article  PubMed  CAS  Google Scholar 

  63. Johnson CE, Carlin SA, Super DM et al. Cefixime compared with amoxicillin for treatment of acute otitis media. J Pediatr 1991; 119:117–22.

    Article  PubMed  CAS  Google Scholar 

  64. Karalus R, Campagnari A. Moraxella catarrhalis: a review of an important human mucosal pathogen. Microbes Infect 2000; 2(5):547–59.

    Article  PubMed  CAS  Google Scholar 

  65. Kilpi T, Herva E, Kaijalainen T et al. Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr Infect Dis J 2001; 20(7):654–62.

    Article  PubMed  CAS  Google Scholar 

  66. Klingman KL, Murphy TF. Purification and characterization of a high-molecular-weight outer membrane protein of Moraxella (Branhamella) catarrhalis. Infect Immun 1994; 62:1150–5.

    PubMed  CAS  Google Scholar 

  67. Klingman KL, Pye A, Murphy TF et al. Dynamics of respiratory tract colonization by Moraxella (Branhamella) catarrhalis in bronchiectasis. Am J Respir Crit Care Med 1995; 152:1072–8.

    PubMed  CAS  Google Scholar 

  68. Kyd J, John A, Cripps A et al. Investigation of mucosal immunisation in pulmonary clearance of Moraxella (Branhamella) catarrhalis. Vaccine 2000; 18:398–406.

    Article  Google Scholar 

  69. Kyd JM, Cripps AW, Murphy TF. Outer membrane antigen expression by Branhamella catarrhalis influences pulmonary clearance. J Med Microbiol 1998; 47:159–68.

    Article  PubMed  CAS  Google Scholar 

  70. LaFontaine ER, Wagner NJ, Hansen EJ. Expression of the Moraxella catarrhalis UspA1 protein undergoes phase variation and is regulated at the transcriptional level. J Bacteriol 2001; 183(5):1540–51.

    Article  PubMed  CAS  Google Scholar 

  71. Leach AJ, Boswell JB, Asche V et al. Bacterial colonization of the nasopharynx predicts very early onset and persistence of otitis media in Australian Aboriginal infants. Pediatr Infect Dis J 1994; 13:983–9.

    Article  PubMed  CAS  Google Scholar 

  72. Luke CJ, Marshall MA, Zahradnik JM et al. Growth-inhibiting antibody responses of humans vaccinated with recombinant outer surface protein A or infected with Borrelia burgdorferi or both. J Infect Dis 2000; 181:1062–8.

    Article  PubMed  CAS  Google Scholar 

  73. Luke NR, Campagnari AA. Construction and characterization of Moraxella catarrhalis mutants defective in expression of transferrin receptors. Infect Immun 1999; 67:5815–9.

    PubMed  CAS  Google Scholar 

  74. Luke NR, Russo TA, Luther N et al. The use of an isogenic mutant, constructed in Moraxella catarrhalis, to identify a protective epitope of OMP B1 defined by monoclonal antibody 11C6. Infect Immun 1999; 67(2):681–7.

    PubMed  CAS  Google Scholar 

  75. Maciver I, Unhanand M, McCracken GH Jr et al. Effect of immunization on pulmonary clearance of Moraxella catarrhalis in an animal model. J Infect Dis 1993; 168:469–72.

    Article  PubMed  CAS  Google Scholar 

  76. Mathers KE, Goldblatt D, Aebi C et al. Characterisation of an outer membrane protein of Moraxella catarrhalis. FEMS Immunol Med Microbiol 1997; 19:231–6.

    Article  PubMed  CAS  Google Scholar 

  77. McKenzie H, Morgan MG, Jordens JZ et al. Characterisation of hospital isolates of Moraxella (Branhamella) catarrhalis by SDS-PAGE of whole-cell proteins, immunoblotting and restriction-endonuclease analysis. J Med Microbiol 1992; 37:70–6.

    Article  PubMed  CAS  Google Scholar 

  78. McMichael JC, Fiske MJ, Fredenburg RA et al. Isolation and characterization of two proteins from Moraxella catarrhalis that bear a common epitope. Infect Immun 1998; 66:4374–81.

    PubMed  CAS  Google Scholar 

  79. Monso E, Ruiz J, Rosell A et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995; 152:1316–20.

    PubMed  CAS  Google Scholar 

  80. Morgan MG, McKenzie H, Enright MC et al. Use of molecular methods to characterize Moraxella catarrhalis strains in a suspected outbreak of nosocomial infection. Eur J Clin Microbiol Infect Dis 1992; 11:305–12.

    Article  PubMed  CAS  Google Scholar 

  81. Murphy TF. Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response. Microbiol Rev 1996; 60:267–79.

    PubMed  CAS  Google Scholar 

  82. Murphy TF. Branhamella catarrhalis: epidemiological and clinical aspects of a human respiratory tract pathogen. Thorax 1998; 53:124–8.

    Article  PubMed  CAS  Google Scholar 

  83. Murphy TF, Brauer AL, Yuskiw N et al. Antigenic structure of outer membrane protein E of Moraxella catarrhalis and construction and characterization of mutants. Infect Immun 2000; 68(11):6250–6.

    Article  PubMed  CAS  Google Scholar 

  84. Murphy TF, Brauer AL, Yuskiw N et al. Conservation of outer membrane protein E among strains of Moraxella catarrhalis. Infect Immun 2001; 69(6):3576–80.

    Article  PubMed  CAS  Google Scholar 

  85. Murphy TF, Kirkham C, Denardin E et al. Analysis of antigenic structure and human immune response to outer membrane protein CD of Moraxella catarrhalis. Infect Immun 1999; 67:4578–85.

    PubMed  CAS  Google Scholar 

  86. Murphy TF, Kirkham C, Lesse AJ. The major heat-modifiable outer membrane protein CD is highly conserved among strains of Branhamella catarrhalis. Mol Microbiol 1993; 10:87–98.

    Article  PubMed  CAS  Google Scholar 

  87. Murphy TF, Kyd JM, John A et al. Enhancement of pulmonary clearance of Moraxella (Branhamella) catarrhalis following immunization with outer membrane protein CD in a mouse model. J Infect Dis 1998; 178:1667–75.

    Article  PubMed  CAS  Google Scholar 

  88. Myers LE, Yang Y-P, Du R-P et al. The transferrin binding protein B of Moraxella catarrhalis elicits bactericidal antibodies and is a potential vaccine antigen. Infect Immun 1998; 66:4183–92.

    PubMed  CAS  Google Scholar 

  89. Nicotra B, Rivera M, Luman JI et al. Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease. Arch Intern Med 1986; 146:890–3.

    Article  PubMed  CAS  Google Scholar 

  90. Ninane G, Joly J, Kraytman M. Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture. Br Med J 1978; 1:276–8.

    Article  PubMed  CAS  Google Scholar 

  91. Owen MJ, Anwar R, Nguyen HK et al. Efficacy of Cefixime in the treatment of acute otitis media in children. AJDC 1993; 147:81–6.

    PubMed  CAS  Google Scholar 

  92. Patterson JE, Patterson TF, Farrel P et al. Evaluation of restriction endonuclease analysis as an epidemiologic typing system for Branhamella catarrhalis. J Clin Microbiol 1989; 27:944–6.

    PubMed  CAS  Google Scholar 

  93. Patterson TF, Patterson JE, Masecar BL et al. A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis. J Infect Dis 1988; 157:996–1001.

    Article  PubMed  CAS  Google Scholar 

  94. Pela R, Marchesani F, Agostinelli C et al. Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation. Monaldi Arch Chest Dis 1998; 53:3–262.

    Google Scholar 

  95. Post JC, Preston RA, Aul JJ et al. Molecular analysis of bacterial pathogens in otitis media with effusion. JAMA 1995; 273:1598–604.

    Article  PubMed  CAS  Google Scholar 

  96. Rahman M, Holme T. Antibody response in rabbits to serotype-specific determinants in lipopolysac-charides from Moraxella catarrhalis. J Med Microbiol 1996; 44:348–54.

    Article  PubMed  CAS  Google Scholar 

  97. Rahman M, Jonsson A-B, Holme T. Monoclonal antibodies to the epitope α-Gal-(l-4)-ß-gal-(1-of Moraxella catarrhalis LPS react with a similar epitope in type IV pili of Neisseria meningitidis. Microb Pathogen 1998; 24:299-308.

    Article  CAS  Google Scholar 

  98. Reddy MS, Murphy TF, Faden HS et al. Middle ear mucin glycoprotein: purification and interaction with nontypable Haemophilus influenzae and Moraxella catarrhalis. Otolaryngol Head Neck Surg 1997; 116:175–89.

    Article  PubMed  CAS  Google Scholar 

  99. Retzer MD, Yu R-H, Schryvers AB. Identification of sequences in human transferrin that bind to the bacterial receptor protein, transferrin-binding protein B. Mol Microbiol 1999; 32:111–21.

    Article  PubMed  CAS  Google Scholar 

  100. Richards SJ, Greening AP, Enright MC et al. Outbreak of Moraxella catarrhalis in a respiratory unit. Thorax 1993; 48:91–2.

    Article  PubMed  CAS  Google Scholar 

  101. Ryan AF. Immune-mediated otitis media in an animal model. Ann Otol Rhinol Laryngol 1988; 97:24–7.

    Google Scholar 

  102. Sarwar J, Campagnari AA, Kirkham C et al. Characterization of an antigenically conserved heat-modifiable major outer membrane protein of Branhamella catarrhalis. Infect Immun 1992; 60:804–9.

    PubMed  CAS  Google Scholar 

  103. Sethi S, Hill SL, Murphy TF. Serum antibodies to outer membrane proteins of Moraxella (Branhamella) catarrhalis in patients with bronchiectasis: identification of OMP B1 as an important antigen. Infect Immun 1995; 63:1516–20.

    PubMed  CAS  Google Scholar 

  104. Sethi S, Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000. A state of the art review. Clin Microbiol Rev 2001; 14(2):336–63.

    Article  PubMed  CAS  Google Scholar 

  105. Sethi S, Surface JM, Murphy TF. Antigenic heterogeneity and molecular analysis of CopB of Branhamella (Moraxella) catarrhalis. Infect Immun 1997; 65:3666–71.

    PubMed  CAS  Google Scholar 

  106. Soler N, Torres A, Ewig S et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 1998; 157:1498–505.

    PubMed  CAS  Google Scholar 

  107. Stenfors L-E, Raisanen S. Quantitative analysis of the bacterial findings in otitis media. J. Laryngol. Otol. 1990; 104:749–57.

    Article  PubMed  CAS  Google Scholar 

  108. Stenfors L-E, Raisanen S. Secretory IgA-, IgG- and C3b-coated bacteria in the nasopharynx of otitis-prone and nonotitis-prone children. Acta Otolaryngol 1993; 113:191–5.

    Article  PubMed  CAS  Google Scholar 

  109. Takada R, Harabuchi Y, Himi T et al. Antibodies specific to outer membrane antigens of Moraxella catarrhalis in sera and middle ear effusions from children with otitis media with effusion. Intl. J. Ped. Otorhinolaryngol. 1998; 46:185–95.

    Article  CAS  Google Scholar 

  110. Thanassi WT, Schoen RT. The Lyme disease vaccine: conception, development, and implementation. Ann Intern Med 2000; 132:661–8.

    PubMed  CAS  Google Scholar 

  111. Unhanand M, Maciver I, Ramilo O et al. Pulmonary clearance of Moraxella catarrhalis in an animal model. J Infect Dis 1992; 165:644–50.

    Article  PubMed  CAS  Google Scholar 

  112. Van Hare GF, Shurin PA, Marchant CD et al. Acute otitis media caused by Branhamella catarrhalis: biology and therapy. Rev Infect Dis 1987; 9:16–27.

    Article  PubMed  CAS  Google Scholar 

  113. Vaneechoutte M, Verschraegen G, Claeys G et al. Serological typing of Branhamella catarrhalis strains on the basis of lipopolysaccharide antigens. J Clin Microbiol 1990; 28:182–7.

    PubMed  CAS  Google Scholar 

  114. Vaneechoutte M, Verschraegen G, Claeys G et al. Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum. J Clin Microbiol 1990; 28:2674–80.

    PubMed  CAS  Google Scholar 

  115. Verghese A, Berk SL. Moraxella (Branhamella) catarrhalis. Infect Dis Clin No Amer 1991; 5:523–38.

    Google Scholar 

  116. Wald ER, Reilly JS, Casselbrant M et al. Treatment of acute maxillary sinusitis in childhood: a comparative study of amoxicillin and cefaclor. J Pediatr 1984; 104:297–302.

    Article  PubMed  CAS  Google Scholar 

  117. West M, Berk SL, Smith JK. Branhamella catarrhalis pneumonia. South Med J 1982; 75:1021–3.

    Article  PubMed  CAS  Google Scholar 

  118. Yang Y-P, Myers LE, McGuinness U et al. The major outer membrane protein, CD, extracted from Moraxella (Branhamella) catarrhalis is a potential vaccine antigen that induces bactericidal antibodies. FEMS Immunol Med Microbiol 1997; 17:187–99.

    Article  PubMed  CAS  Google Scholar 

  119. Yu R, Schryvers AB, The interaction between human transferrin and transferrin binding protein 2 from Moraxella (Branhamella) catarrhalis differs from that of other human pathogens. Microb Pathogen 1993; 15:433–45.

    Article  CAS  Google Scholar 

  120. Yu R-H, Bonnah RA, Ainsworth S, Schryvers AB. Analysis of the immunological responses to transferrin and lactoferrin receptor proteins from Moraxella catarrhalis. Infect Immun 1999; 67:3793–9.

    PubMed  CAS  Google Scholar 

  121. Zaleski A, Scheffler NK, Densen P et al. Lipooligosacchrdie Pk (Gal α-4Galß1-4GlC) epitope of Moraxella catarrhalis is a factor in resistance to bactericidal activity mediated by normal human serum. Infect Immun 2000; 68(9):5261–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Timothy F. Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Murphy, T.F. (2003). Moraxella catarrhalis . In: New Bacterial Vaccines. Medical Intelligence Unit. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0053-7_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-0053-7_14

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4902-0

  • Online ISBN: 978-1-4615-0053-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation